Atypical Takotsubo Cardiomyopathy Presenting As Acute Coronary Syndrome: A Case Report

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2022 Oct 31

PMID 36312483

Authors

Zi-Han Wang

Jia-Rong Fan

Gao-Yu Zhang

Xian-Lun Li

Lin Li

Affiliations

Soon will be listed here.

Abstract

Background: Takotsubo cardiomyopathy (TS) is a rare acute cardiac disease with clinical features, symptoms, and electrocardiographic manifestations similar to those of acute myocardial infarction. We present the case of a patient with TS caused by a pheochromocytoma, which was confirmed by the postoperative pathology. Furthermore, we present the patient's subsequent management, treatment, and outcome.

Case Summary: A 64-year-old woman was admitted to the hospital with episodic chest pain and palpitations, electrocardiogram (ECG) findings suggestive of high lateral wall myocardial infarction, echocardiogram showing left ventricular wall segmental motion abnormalities, and elevated levels of the myocardial marker troponin. The patient underwent coronary angiography, which revealed unobstructed blood flow without obvious stenosis. During their hospitalization, the patient had paroxysmal elevation of blood pressure accompanied by palpitations and profuse sweating, with elevated blood catecholamine levels during seizures. Subsequent computerized tomography of the adrenal glands revealed the presence of a nodule in the right adrenal, which was resected and determined to be an adrenal pheochromocytoma. Therefore, the diagnosis of pheochromocytoma-induced atypical TS was made. The patient had an uneventful postoperative recovery.

Conclusion: Cardiologists should consider pheochromocytoma in patients with TS. Early detection allows timely intervention, benefiting patients.

Citing Articles

A case report and literature review: pheochromocytoma-mediated takotsubo cardiomyopathy, which is similar to acute myocardial infarction.

Zhang Z, Guo X, Wang J, Wang S, Wang Y Front Cardiovasc Med. 2023; 10:1194814.

PMID: 37424925 PMC: 10327548. DOI: 10.3389/fcvm.2023.1194814.

References

Tofield A . Hikaru Sato and Takotsubo cardiomyopathy. Eur Heart J. 2016; 37(37):2812. DOI: 10.1093/eurheartj/ehw367. View

Ueyama T, Hano T, Kasamatsu K, Yamamoto K, Tsuruo Y, Nishio I . Estrogen attenuates the emotional stress-induced cardiac responses in the animal model of Tako-tsubo (Ampulla) cardiomyopathy. J Cardiovasc Pharmacol. 2004; 42 Suppl 1:S117-9. DOI: 10.1097/00005344-200312001-00024. View

Kido K, Guglin M . Drug-Induced Takotsubo Cardiomyopathy. J Cardiovasc Pharmacol Ther. 2017; 22(6):552-563. DOI: 10.1177/1074248417708618. View

Lyon A, Bossone E, Schneider B, Sechtem U, Citro R, Underwood S . Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2015; 18(1):8-27. DOI: 10.1002/ejhf.424. View

Y-Hassan S, Tornvall P . Epidemiology, pathogenesis, and management of takotsubo syndrome. Clin Auton Res. 2017; 28(1):53-65. PMC: 5805795. DOI: 10.1007/s10286-017-0465-z. View

Templin C, Ghadri J, Diekmann J, Napp L, Bataiosu D, Jaguszewski M . Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015; 373(10):929-38. DOI: 10.1056/NEJMoa1406761. View

Ferreira V, Marcelino M, Piechnik S, Marini C, Karamitsos T, Ntusi N . Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. J Am Coll Cardiol. 2016; 67(20):2364-2374. DOI: 10.1016/j.jacc.2016.03.543. View

Hurst R, Prasad A, Askew 3rd J, Sengupta P, Tajik A . Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 2010; 3(6):641-9. DOI: 10.1016/j.jcmg.2010.01.009. View

Ghadri J, Cammann V, Napp L, Jurisic S, Diekmann J, Bataiosu D . Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome: Data From the International Takotsubo Registry. JAMA Cardiol. 2016; 1(3):335-40. DOI: 10.1001/jamacardio.2016.0225. View

10.

Kato K, Lyon A, Ghadri J, Templin C . Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017; 103(18):1461-1469. DOI: 10.1136/heartjnl-2016-309783. View

11.

Prasad A, Lerman A, Rihal C . Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008; 155(3):408-17. DOI: 10.1016/j.ahj.2007.11.008. View

12.

Nolting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M . Personalized Management of Pheochromocytoma and Paraganglioma. Endocr Rev. 2021; 43(2):199-239. PMC: 8905338. DOI: 10.1210/endrev/bnab019. View

13.

Ono R, Menezes Falcao L . Takotsubo cardiomyopathy systematic review: Pathophysiologic process, clinical presentation and diagnostic approach to Takotsubo cardiomyopathy. Int J Cardiol. 2016; 209:196-205. DOI: 10.1016/j.ijcard.2016.02.012. View

14.

Bonnemeier H, Demming T, Weidtmann B, Ortak J, Burgdorf C, Reppel M . Differential heart rate dynamics in transient left ventricular apical and midventricular ballooning. Heart Rhythm. 2010; 7(12):1825-32. DOI: 10.1016/j.hrthm.2010.08.025. View

15.

Falhammar H, Kjellman M, Calissendorff J . Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center. Endocrine. 2018; 62(3):566-575. PMC: 6244895. DOI: 10.1007/s12020-018-1734-x. View

16.

Paur H, Wright P, Sikkel M, Tranter M, Mansfield C, OGara P . High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012; 126(6):697-706. PMC: 4890655. DOI: 10.1161/CIRCULATIONAHA.112.111591. View